Institutional Ownership Galectin Therapeutics Inc (GALT)
This table provides information about the institutional ownership of Galectin Therapeutics Inc (GALT). We have compiled data on the 93 institutions that hold shares in the stock, with a total of 11.1 Million shares, which have been reported (via 13F filing form) to have a value of $61.1 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Bradley & Co. Private Wealth Management, LLC
|
Nov 12, 2025 Q3 2025 |
1,000
shares
|
$5,500
0.0% of portfolio
|
Q1 2021
New holding
|
|
|
Nisa Investment Advisors, LLC
|
Oct 23, 2025 Q3 2025 |
716
shares
|
$3,938
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Royal Bank Of Canada
Toronto, A6 |
Nov 14, 2025 Q3 2025 |
476
shares
|
$2,618
0.0% of portfolio
|
Q2 2025
Added 4483.27%
|
|
|
Cwm, LLC
|
Oct 15, 2025 Q3 2025 |
330
shares
|
$1,815
0.0% of portfolio
|
Q3 2025
Reduced 73.79%
|
|
|
Global Retirement Partners, LLC
|
Oct 21, 2025 Q3 2025 |
250
shares
|
$1,375
0.0% of portfolio
|
Q2 2023
Reduced 28.57%
|
|
|
Russell Investments Group, Ltd.
|
Nov 13, 2025 Q3 2025 |
179
shares
|
$984
0.0% of portfolio
|
Q2 2025
Reduced 65.51%
|
|
|
Salem Investment Counselors Inc
Winston Salem, NC |
Oct 07, 2025 Q3 2025 |
167
shares
|
$918
0.0% of portfolio
|
Q2 2019
New holding
|
|
|
Citigroup Inc
|
Nov 10, 2025 Q3 2025 |
136
shares
|
$748
0.0% of portfolio
|
Q3 2025
Added 223.81%
|
|
|
Ever Source Wealth Advisors, LLC
|
Nov 10, 2025 Q3 2025 |
77
shares
|
$423
0.0% of portfolio
|
Q3 2025
Reduced 52.17%
|
|
|
Srs Capital Advisors, Inc.
Denver, CO |
Nov 14, 2025 Q3 2025 |
52
shares
|
$286
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Optiver Holding B.V.
Amsterdam, P7 |
Nov 10, 2025 Q3 2025 |
18
shares
|
$99
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
True Wealth Design, LLC
Akron, OH |
Oct 21, 2025 Q3 2025 |
17
shares
|
$93
0.0% of portfolio
|
Q3 2025
Reduced 22.73%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Aug 12, 2025 Q2 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q2 2025
New holding
|
|